CClinicalTrials.gg
CompletedNCT03256175Updated Oct 25, 2017

The Effect of Peri-percutaneous Coronary Intervention Oxygenation on Myocardial Protection & Cardiovascular Fitness

An interventional study of Percutaneous Coronary Intervention in Myocardial Ischemia and Cardiovascular Morbidity, sponsored by University of Malaya. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-25.

Sponsored by University of Malaya · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Elective percutaneous coronary intervention (PCI) is often associated with myocardial necrosis evidenced by peri-procedural troponin release. This is a surrogate for subsequent cardiovascular events. There is no study on the effect of peri-PCI oxygenation in in myocardial protection and cardiopulmonary fitness outcome. Patients with higher baseline cardiopulmonary fitness will have lower mortality.

This study is to assess the utility of oxygen to reduce ischaemia in patients with significant stable coronary artery disease scheduled for elective PCI. The secondary objective is to evaluate further effect of peri- PCI oxygenation on cardiovascular fitness and autonomic response.

Read the detailed description

OBJECTIVE: This study is to assess the utility of oxygen to reduce ischaemia in patients with significant stable coronary artery disease scheduled for elective PCI. The secondary objective is to evaluate further effect of peri- PCI oxygenation on cardiovascular fitness and autonomic response.

STUDY DESIGN: Randomized double blinded prospective pilot study SAMPLE SIZE: 30 patients scheduled for elective for PCI randomized to 2 groups, oxygen group ( 15L/min) and air group METHOD: Patient whom fulfil inclusion criteria were recruited and randomized to 2 groups via computer allocation system. The assigned inhaled gas will be delivered via high-flow mask at 15L/min for a minimum of 30 minutes immediately prior to and continued throughout the PCI procedure. Patients were blinded throughout the procedure but the practising cardiologist and staff nurses were not blinded. Routine care continued post PCI. Blood sampling for Troponin I was taken at 6 hours and 24 hours following stent implantation. Patients were discharged one day after the procedure as per current routine practice.

Patients were given routine follow up with the cardiac rehabilitation clinic in 4 weeks time post discharge. EST was arranged 6 weeks post procedure PRIMARY OUTCOME MEASURE: Troponin I at 6 and 24 hours SECONDARY OUTCOME MEASURE: METs, Heart Rate Recovery, Chronotropic Index

02

Conditions studied

  • Myocardial Ischemia
  • Cardiovascular Morbidity

Browse trials for

Keywords

  • Myocardial Protection
  • Oxygen
  • Exercise Test
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients aged >18 years
  • Haemodynamically important coronary artery disease (>70% luminal stenosis angiographically in ≥1 major epicardial coronary artery

Exclusion criteria

Exclusion Criteria:

  • Significant chronic airways disease with type-2 respiratory failure precluding safe use of oxygen
  • Coronary stenoses where evidence of plaque instability is evident e.g. rest pain, visual evidence of thrombus, elevation of Troponin T at baseline
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Oxygen

    Patient was give 15L/min of Oxygen via HFM 30 mins before and continue through out the procedure. 6 weeks post procedure, EST was arranged

    Procedure: Percutaneous Coronary Intervention

  • Placebo comparator
    Air

    Patient was given Facemask without oxygen through out the procedure. 6 weeks post procedure, EST was arranged

    Procedure: Percutaneous Coronary Intervention

Interventions

  • ProcedurePercutaneous Coronary Intervention

    PCI technique (e.g. pre-dilatation vs. direct stenting and stent choice) was left to operator discretion. Stent post dilatation was permitted as per individual operator practice

05

What researchers measure

Primary outcomes

  1. The primary objective of this study was to assess the myocardial protection

    this is done by comparing changes Troponin I at 6 (baseline) to 24 hours between both study arms.

    Time frame: 6 hours and 24 hours after the procedure

Secondary outcomes

  1. To assess the utility of peri-PCI oxygenation to improve cardiovascular fitness

    assessed by Functional capacity in METs-Maximum METs achieved

    Time frame: 6 weeks post procedure

  2. To assess the utility of peri-PCI oxygenation to improve autonomic response

    assessed by Heart Rate Recovery

    Time frame: 6 weeks post procedure

  3. To assess the utility of peri-PCI oxygenation to improve autonomic response

    assessed by Chronotropic Index

    Time frame: 6 weeks post procedure

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03256175
Lead sponsor
University of Malaya
Responsible party
Sponsor
First posted
Aug 21, 2017
Start date
Jul 1, 2015
Primary completion
Dec 31, 2015
Completion
Jun 30, 2016
Last update
Oct 25, 2017

Study contacts

Soo Chin Chan, MBBS
principal investigator · schin1022@yahoo.com
Anwar Suhami, MBBS
study chair · anwar@ummc.edu.my

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion